It has been reported that miRNAs may control the drug response of MM cells through regulation of the apoptotic or proliferative pathways, which include p53 [46], which is a transcription factor that can stimulate tumor suppressor miRNAs or even inhibit some oncomiRNAs [47]. Here, TP53 is linked to Miyoshi myopathy.